ISL1 and teratoma: It has been reported that early-stage SSEA-1+/Isl-1+ CPCs derived from Rhesus ESCs and transplanted in an allogeneic setting reduce scar tissue size and differentiate into ventricular myocytes with no evidence of teratoma formation [7].